Medicine guide
AMTAGVI
As listed in the register: AMTAGVI
72000000000 cells · suspension
- Prescription only
- Cancer treatments and immune-system medicines
- Active substance
- Lifileucel
- Made by
- Iovance Biotherapeutics, Inc.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Medicine groupCancer treatments and immune-system medicinesL01XL11
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Details
| Made by | Iovance Biotherapeutics, Inc. |
|---|---|
| Active substance | Lifileucel |
| Used in | Cancer treatments and immune-system medicines |
| Strength | 72000000000 cells |
| Form | suspension |
| Classification | L01XL11 · Cancer treatments and immune-system medicines |
| Route | intravenous |
| Dispensing (as stated by the register) | SCHEDULE D · PRESCRIPTION |
| Status | Approved |
| Marketed | No — authorised but not currently marketed, according to the register |
| DIN | 02560232 |
| DPD drug code | 106331 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.